Characterization of a Human—Human Hybridoma Antibody, C-OU1, Directed Against a Colon Tumor-Associated Antigen
Authors:
- Per Borup-ChristensenPBPer Borup-Christensen
- Henrik DitzelHDHenrik Ditzel
- John ChemnitzJCJohn Chemnitz
- Helmuth HaasHHHelmuth Haas
- Jens Christian JenseniusJJJens Christian Jensenius
- 1 April 1992
- journal article
- Published by SAGE Publications in Hybridoma
- Vol. 11 (2) , 121-134
Abstract
The human hybridoma cell line, B9165, was obtained after fusion of lymphocytes from lymph nodes draining the tumor region in a patient with adenocarcinoma of the colon with the human B-lymphoblastoid cell line WI-L2-729-HF2 (729-HF2). B9165 secretes the human monoclonal antibody, C-OU1 (IgM, kappa). Immunocytochemical and immunohistochemical analysis showed that the antibody bound to a differentiation antigen. Electron microscopy of colonic adenocarcinoma cells, intact tumor and colonic epithelium by the immunogold technique demonstrated that the C-OU1 antibody reacted with a molecule associated with areas of disruption of the intermediate filaments in the cytoplasm of the tumor cells. No reaction was seen with intermediate filaments in normal colonic epithelium. The molecular weight of the antigen was shown to be 43 Kda by SDS-PAGE and Western blotting of tumor extracts, and isoelectric focusing of sonicated extracts demonstrated reaction with molecular species of pI 5.4-6.2. These findings suggest that the C-OU1 antigen is a modified cytokeratin 18. The B9165 cell line has proved to be quite stable, and the antibody is of potential clinical value. Its usefulness for localizing tumors in patients is being investigated.Keywords
This publication has 19 references indexed in Scilit:
- Challenges to the Therapy of Cancer With Monoclonal AntibodiesJNCI: Journal of the National Cancer Institute, 1991
- A method for blocking antigen-independent binding of human IgM to frozen tissue sections when screening human hybridoma antibodiesJournal of Immunological Methods, 1990
- Human‐human hybridoma producing monoclonal antibodies against colorectal cancer‐associated antigensAPMIS, 1990
- Human Monoclonal Antibodies against Cytokeratin 18 Generated from Patients with Gastric CancerJapanese Journal of Cancer Research, 1989
- Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant diseasesNuclear Medicine Communications, 1988
- A Human Monoclonal Antibody to Cytokeratin Intermediate Filament Antigens Derived from a Tumor Draining Lymph NodeHybridoma, 1988
- Characterization of a Lectin in Human Plasma Analogous to Bovine ConglutininScandinavian Journal of Immunology, 1987
- Genetically Stable Human Hybridomas Secreting Tumor-Reactive Human Monoclonal IgMCancer Investigation, 1987
- Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.Journal of Experimental Medicine, 1983
- The Cross-linking of Proteins with Glutaraldehyde and its use for the preparation of immunoadsorbentsImmunochemistry, 1969